                                                Table 14.1/4
                                Demographics and Baseline to Characteristics
                                             Specify Population

                                             Placebo     Drug 10mg    Drug 20mg    Competitor
                                              (N=36)       (N=38)       (N=38)       (N=38)
            ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

            Age  N                              36           38           38           38
                 Mean                      51.7 (15.0)  46.9 (14.7)  49.1 (14.7)  50.9 (14.6)
                 Median                        52.5         46.0         50.5         53.0
                 Q1 - Q3                   40.8 - 60.5  35.0 - 56.8  44.2 - 61.0  39.2 - 64.0
                 Range                       24 - 75      22 - 73      19 - 71      21 - 75

            Sex  Male                      24 ( 66.7%)  18 ( 47.4%)  21 ( 55.3%)  26 ( 68.4%)
                 Female                    12 ( 33.3%)  20 ( 52.6%)  17 ( 44.7%)  12 ( 31.6%)

            Race White                     31 ( 86.1%)  32 ( 84.2%)  32 ( 84.2%)  35 ( 92.1%)
                 Black or African American  3 (  8.3%)   3 (  7.9%)   6 ( 15.8%)   1 (  2.6%)
                 Asian or Pacific Islander  1 (  2.8%)   2 (  5.3%)   0 (  0.0%)   1 (  2.6%)
                 Unknown                    1 (  2.8%)   1 (  2.6%)   0 (  0.0%)   1 (  2.6%)





















Special symbols µ Ω £ there to mess things up:

Time                                                                                             Page 1 of 1
